| 股票 | 标签 | 富途行业 | PE | PB | 股息率 | 分红率 | 毛利率 | ROE | 固定资产 | 负债率 | OCF/市值 | 营收增速 | 利润增速 | 近60日 | YTD | 近一年 | 距52周高 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 白云山 00874 | 现金流红利 | 中医药 | 7.4 | 0.49 | 6.4% | 48% | 16% | 8% | 7% | 53% | 15.8% | +8% | +7% | -8% | -20% | -21% | 69% | 220 |
| 神威药业 02877 | 轻资产现金牛 | 中医药 | 7.4 | 0.72 | 7.3% | 54% | 72% | 12% | 12% | 25% | 10.0% | -13% | +18% | -2% | +2% | +4% | 83% | 68 |
| 中国中药 00570 | 亏损或困境 | 中医药 | -5.8 | 0.30 | 0.0% | — | 48% | -2% | 19% | 29% | 22.5% | -7% | -2406% | -10% | -36% | -39% | 50% | 68 |
| 同仁堂国药 03613 | 轻资产现金牛 | 中医药 | 13.8 | 1.23 | 6.7% | 93% | 61% | 10% | 5% | 6% | 12.5% | -6% | -21% | -11% | -26% | -32% | 66% | 50 |
| 同仁堂科技 01666 | 现金流红利 | 中医药 | 11.4 | 0.48 | 6.5% | 75% | 38% | 6% | 18% | 25% | 34.5% | -7% | -22% | -8% | -25% | -33% | 66% | 40 |
| 健倍苗苗 02161 | 定价权·品牌 | 中医药 | 7.7 | 1.44 | 5.2% | 40% | 56% | 19% | 10% | 36% | 10.5% | +7% | +4% | -18% | -29% | -32% | 62% | 16 |
| 现代中药集团 01643 | 重资产陷阱 | 中医药 | -11.6 | 1.04 | 0.0% | — | 16% | -3% | 35% | 8% | -11.5% | -29% | -247% | -42% | +53% | +8% | 24% | 6 |
| 福森药业 01652 | 中性 | 中医药 | -185.0 | 1.38 | 0.0% | — | 40% | -3% | 28% | 72% | 19.2% | -12% | +94% | -30% | -8% | +118% | 42% | 5 |
| 位元堂 00897 | 中性 | 中医药 | 76.2 | 0.29 | 0.0% | 0% | 53% | 0% | 36% | 27% | 20.7% | -8% | -42% | -5% | -22% | -5% | 60% | 3 |
| 中国智能健康 00348 | 亏损或困境 | 中医药 | -1.9 | -1.30 | 0.0% | — | 34% | 0% | 0% | 117% | 23.8% | -12% | +94% | +0% | -48% | -56% | 32% | 1 |
点表头排序。市值单位亿港元;财务为最近年报(futu 筛选器);分红率 = 股息率 × PE;OCF/市值 = 经营现金流 ÷ 市值(无 FCF);距52周高 = 现价 / 52 周最高。